Erasca, Inc. (ERAS) vs Lyell Immunopharma, Inc. (LYEL)
Detailed comparison between Erasca, Inc., Lyell Immunopharma, Inc..Total Return (%)
Erasca, Inc. (ERAS)Lyell Immunopharma, Inc. (LYEL)
Which stock do you think will perform better?
Erasca, Inc.
ERAS
Lyell Immunopharma, Inc.
LYEL
| Metric | Erasca, Inc. (ERAS) | Lyell Immunopharma, Inc. (LYEL) |
|---|---|---|
| Current Price | $2.88 | $17.60 |
| Change | 0.11 (3.77%) | 0.17 (0.98%) |
| Market Cap | $0.82B | $0.37B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -3.90 | -20.95 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.30 | $20.80 |
| 52-Week Low | $1.01 | $7.65 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-0.43 | $-22.75 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ERAS | 27.09% | 49.48% | 6.85% | -83.45% | -83.45% | -83.45% |
| LYEL | 3.35% | 52.78% | -7.37% | -94.79% | -94.79% | -94.79% |